Establishment of nedaplatin safety dose formula based on renal function for combination chemotherapy with nedaplatin and 5-fluorouracil in patients with esophageal cancer.

Takahashi, Masaya; Takahashi, Katsuyuki; Muguruma, Kazuya; Ohira, Masaichi; Nagayama, Katsuya

Takahashi, Masaya; Takahashi, Katsuyuki; Muguruma, Kazuya; Ohira, Masaichi; Nagayama, Katsuya.

Afiliação

Takahashi M; Department of Pharmacy, Osaka City University Hospital, 1-5-7 Asahi-machi, Abeno-ku, Osaka, 545-8586, Japan.
Takahashi K; Department of Pharmacy, Osaka City University Hospital, 1-5-7 Asahi-machi, Abeno-ku, Osaka, 545-8586, Japan. k.taka@med.osaka-cu.ac.jp.
Muguruma K; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka City University, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Ohira M; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka City University, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Nagayama K; Department of Pharmacy, Osaka City University Hospital, 1-5-7 Asahi-machi, Abeno-ku, Osaka, 545-8586, Japan.

Int J Clin Oncol ; 27(2): 348-353, 2022 Feb.

Article em En | MEDLINE | ID: mdl-34686932

Assuntos

Neoplasias Esofágicas; Fluoruracila; Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos; Quimioterapia Combinada; Neoplasias Esofágicas/tratamento farmacológico; Fluoruracila/efeitos adversos; Humanos; Rim/fisiologia; Compostos Organoplatínicos; Estudos Retrospectivos

Palavras-chave

Creatinine clearance; Esophageal cancer; Impaired renal function; Ishibashi's formula; Nedaplatin; Thrombocytopenia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Fluoruracila Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google